Novel Lipid-Lowering Therapies and Cardiovascular Outcomes

Dyslipidemia is a well-established risk factor for atherosclerotic cardiovascular disease, and while statins remain the cornerstone of therapy, residual risk persists for many patients. The advent of novel lipid-lowering agents—including PCSK9 inhibitors, bempedoic acid, and ANGPTL3 inhibitors—offers potent LDL reduction beyond statin therapy. Additionally, therapies targeting triglyceride-rich lipoproteins and lipoprotein(a) are under active development, aiming to address previously untreatable risk factors.

Recent outcome trials have demonstrated substantial event reduction with these agents, particularly in high-risk populations. Beyond LDL lowering, attention is turning toward pleiotropic effects such as plaque stabilization and inflammation reduction. This track will explore the expanding therapeutic landscape, discuss barriers to access and cost-effectiveness, and examine integration into treatment guidelines. Participants will also gain insights into ongoing clinical trials that could redefine lipid management strategies in the coming decade.

    Related Conference of Novel Lipid-Lowering Therapies and Cardiovascular Outcomes

    January 12-13, 2026

    12th International Heart Conference

    Dubai, UAE
    March 18-19, 2026

    15th World Heart Congress

    Paris, France
    March 23-24, 2026

    37th Annual Cardiologists Conference

    London, UK
    March 23-24, 2026

    41st World Cardiology Conference

    London, UK
    April 06-07, 2026

    40th World Congress on Heart Diseases

    Paris, France
    April 08-29, 2026

    9th Annual Heart Rhythm Conference

    Vienna, Austria
    April 13-14, 2026

    9th World Heart and Brain Conference

    Tokyo, Japan
    April 15-16, 2026

    8th World Heart Congress

    Tokyo, Japan
    May 14-15, 2026

    5th International Conference on Cardiology

    Rome, Italy
    May 21-22, 2026

    15th World Congress on Cardiology

    London, UK
    June 15-16, 2026

    7th European Summit on Cardiology Research

    Zurich, Switzerland
    July 29-30, 2026

    30th World Cardiology Conference

    Paris, France
    August 17-18, 2026

    4th International Conference on World Heart Care

    Toronto, Canada
    August 24-25, 2026

    15th World Heart Congress

    London, UK
    August 27-28, 2026

    40th European Cardiology Conference

    Berlin, Germany
    November 25-26, 2026

    33rd World Heartcare Summit

    Paris, France

    Novel Lipid-Lowering Therapies and Cardiovascular Outcomes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in